Home・Список акций・Elanco Animal Health Inc

Elanco Animal Health Inc

Открыт

СекторЗдравоохранение

25.56 -0.47

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

25.26

Макс.

25.82

Ключевые показатели
By Trading Economics
Доход	289M 57M
Продажи	227M 1.4B
P/E Средняя по отрасли	372.714 64.641
Прибыль на акцию	0.4
Рентабельность продаж	4.158
Сотрудники	9,400
EBITDA	310M 316M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+17.19% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 авг. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	1.4B 13B
Предыдущая цена открытия	26.03
Предыдущая цена закрытия	25.56

Новостные настроения

By Acuity

40%

60%

128 / 340 Рейтинг в Healthcare

Elanco Animal Health Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 авг. 2026 г., 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 июл. 2026 г., 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 июл. 2026 г., 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 июл. 2026 г., 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 июл. 2026 г., 18:26 UTC

Correlated Moves

News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 июл. 2026 г., 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 июл. 2026 г., 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 июл. 2026 г., 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 июл. 2026 г., 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 июл. 2026 г., 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 июл. 2026 г., 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Сравнение c конкурентами

Изменение цены

Elanco Animal Health Inc Прогноз

Целевая цена

By TipRanks

17.19% рост

Прогноз на 12 месяцев

Средняя 30.14 USD 17.19%

Максимум 32 USD

Минимум 26 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для Elanco Animal Health Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

11 ratings

Покупка

Удержание

Продажа

Основано на мнении 11 аналитиков, присваивавших рейтинги акциям Elanco Animal Health Inc – Данные за последние 3 месяца.

Настроения

By Acuity

128 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.